M1RN34:BVMF
Moderna Inc Bdr
49,08 BRL
arrow_downward
−0,65%(−0,32) 1D
2. lis, 15:28:07 GMT -3 · BRL
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za M1RN34...
Otvori
49,40 BRL
Najviša
50,63 BRL
Najniža
47,98 BRL
Trž. kap.
75,02 mlr.
Prosj. kol.
141,02 tis.
Količina
62,19 tis.
52-tjed. najviša
54,38 BRL
52-tjed. najniža
6,02 BRL
Dionice u optjecaju
399,24 mil.
Broj djelatnika
5 tis.
Otvori
49,40 BRL
Najviša
50,63 BRL
Najniža
47,98 BRL
Trž. kap.
75,02 mlr.
Prosj. kol.
141,02 tis.
Količina
62,19 tis.
52-tjed. najviša
54,38 BRL
52-tjed. najniža
6,02 BRL
Dionice u optjecaju
399,24 mil.
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Stocktwits
·
prije 7 sati
SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’
Investing.com
·
prije 9 sati
Why is Moderna stock rallying today?
TipRanks
·
prije 10 sati
Why Did Moderna Stock Gain (MRNA) in After-Hours Trading on Thursday?
Reuters
·
prije 18 sati
Moderna to replace Warner Bros Discovery on Nasdaq 100
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In 2026, Time ranked Moderna as number one in their World's Most Impactful Companies list. Wikipedia
Moderna Inc Bdr – informacije
Glavni izvršni direktorStéphane Bancel
Zaposlenici4,7 tis.
Osnovanoruj 2010
Sjedište-
Sektor-
Web-lokacijamodernatx.com